Skip to main navigation

Investors
News
- News Releases
- News and Mentions
Presentations & Events
- Presentations
- Events
Stock Performance
- Stock Information
- Analyst Coverage
Financials & Filings
- SEC Filings
- Quarterly Results
Corporate Governance
Resources

News Releases

Year

Mar 11 / 24

Belite Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

Mar 06 / 24

Belite Bio to Host Webcast on March 12, 2024, to Discuss Fourth Quarter and Full Year 2023 Financial Results

Mar 04 / 24

Belite Bio to Participate in the Leerink Partners Global Biopharma Conference

Feb 07 / 24

Belite Bio to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Feb 05 / 24

Belite Bio Receives EMA Approval to Initiate Tinlarebant Phase 3 Clinical Trial for GA in France and Czech Republic

Pagination

First page
Previous page
Page 1
Page 2
Page 3
Current page 4

Displaying 28 - 32 of 32

Belite Bio™ Inc
12750 High Bluff Drive Suite 475,
San Diego CA, 92130 USA

Join our mailing list.

Sign up to receive important updates and news from Belite Bio